Workiva (NYSE: WK) insider files notice to sell 25,980 common shares

Rhea-AI Filing Summary

Workiva insider plans another share sale under SEC Rule 144. A shareholder intends to sell 25,980 shares of common stock through Merrill Lynch on or about 01/02/2026 on the NYSE, with an aggregate market value of $2,250,000. The filing notes that 52,432,466 shares of the issuer’s common stock were outstanding.

The securities to be sold were originally acquired for cash from the issuer on 09/07/2017, totaling 293,468 shares at that time. Over the prior three months, the same seller, Matthew Rizai, reported multiple sales of common stock, including 60,000 shares for $5,307,828 on 12/17/2025, 78,421 shares for $7,294,203 on 11/12/2025, 50,000 shares for $4,434,375 on 10/13/2025, and 40,000 shares for $3,499,992 on 10/03/2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 7545 Ashworth Rd, Suite 100 West Des Moines IA 50266	25980	2250000	52432466	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/07/2017	Cash	Issuer			293468	09/07/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Rizai 2200 N Ocean Blvd, Unit S901 Fort Lauderdale FL 33305	Common	12/17/2025	60000	5307828
Matthew Rizai 2200 N Ocean Blvd, Unit S901 Fort Lauderdale FL 33305	Common	11/12/2025	78421	7294203
Matthew Rizai 2200 N Ocean Blvd, Unit S901 Fort Lauderdale FL 33305	Common	10/13/2025	50000	4434375
Matthew Rizai 2200 N Ocean Blvd, Unit S901 Fort Lauderdale FL 33305	Common	10/03/2025	40000	3499992

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for WK disclose?

The filing discloses that a Workiva shareholder plans to sell 25,980 shares of common stock on or about 01/02/2026 on the NYSE, with an aggregate market value of $2,250,000, under Rule 144.

How many Workiva (WK) shares are planned to be sold and through which broker?

The notice covers the planned sale of 25,980 common shares of Workiva through Merrill Lynch, at 7545 Ashworth Rd, Suite 100, West Des Moines, IA 50266.

How many Workiva (WK) shares were outstanding according to this filing?

The Form 144 states that there were 52,432,466 shares of Workiva common stock outstanding at the time referenced in the notice.

Who is the seller in this Workiva (WK) Form 144 and what prior sales were reported?

The seller is Matthew Rizai, who reported recent sales of Workiva common stock: 60,000 shares for $5,307,828 on 12/17/2025, 78,421 shares for $7,294,203 on 11/12/2025, 50,000 shares for $4,434,375 on 10/13/2025, and 40,000 shares for $3,499,992 on 10/03/2025.

When and how were the Workiva (WK) shares originally acquired by the seller?

The securities to be sold are common shares that were acquired from the issuer for cash on 09/07/2017, in a transaction totaling 293,468 shares, with payment also made in cash on that date.

What representation does the seller make in this Workiva (WK) Form 144?

The seller represents by signing that they do not know any material adverse information about the current or prospective operations of the issuer that has not been publicly disclosed, and acknowledges that intentional misstatements or omissions constitute federal criminal violations.